Market
Neurosoft Bioelectronics raises $7.5m to progress BCI development
Neurosoft Bioelectronics has raised $7.5 million in funding to support clinical trials and US commercialisation of its brain-computer interface (BCI) technology. The capital will advance the company's development and regulatory pathway for its neurotechnology platform.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network